Nomura Mid Cap Growth Fund
IVY FUNDS · 6 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
Nomura Mid Cap Growth Fund is an actively managed U.S. equity fund. 35% of WMGRX’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 87% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2025 Q3
Macquarie Mid Cap Growth Fund seeks to provide growth of capital.
The fund invests primarily in common stocks of mid-capitalization companies selected through bottom-up research for high quality, above-average growth potential, strong fundamentals, and attractive valuations, with at least 80% of assets in mid-cap securities. The fund's returns depend on the Manager's security selection and timing decisions, which may cause performance to diverge from mid-cap market returns.
| Share class | Gross | Net |
|---|---|---|
| WMGRX | 1.45% | 1.29% |
| WMGAX | 1.20% | 1.04% |
| WMGCX | 1.95% | 1.79% |
| WMGYX | 1.20% | 1.04% |
| IYMIX | 0.95% | 0.79% |
| IGRFX | 0.84% | 0.68% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 42.00% · as of 2025 Q3
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 98.98% |
| Cash & short-term | 1.08% |
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Information Technology | 25.3% |
| Industrials | 24.9% |
| Health Care | 17.6% |
| Consumer Discretionary | 10.1% |
| 7 smaller | 22.0% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +9.67% | +11.34% | -16.92% | 15.31% | -18.72% | |
| +9.95% | +12.17% | -16.32% | 15.36% | -18.67% | |
| +9.18% | +9.75% | -18.73% | 15.29% | -18.82% | |
| +9.97% | +12.19% | -15.98% | 15.34% | -18.69% | |
| +10.25% | +13.04% | -14.94% | 15.33% | -18.64% | |
| +10.36% | +13.34% | -14.72% | 15.35% | -18.61% |
These classes hold the same portfolio, so the 4.01pp spread over 5 years is the cost difference between them — roughly 0.80pp a year — not a difference in what they own.
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| NET | CLOUDFLARE INCNET | 3.65% | $245.28 | $109.50M | 446.4K |
| IDXX | IDEXX LABORATORIES INCIDXX | 3.50% | $526.44 | $104.84M | 199.1K |
| MPWR | MONOLITHIC POWER SYSTEMS INCMPWR | 3.36% | $1,382.36 | $100.69M | 72.8K |
| SNOW | SNOWFLAKE INCSNOW | 2.82% | $254.50 | $84.39M | 331.6K |
| FAST | FASTENAL COMPANYFAST | 2.55% | $48.03 | $76.43M | 1.6M |
| DDOG | DATADOG INCDDOG | 2.51% | $260.36 | $75.18M | 288.8K |
| STRL | STERLING INFRASTRUCTURE INCSTRL | 2.48% | $839.36 | $74.49M | 88.7K |
| TECH | BIO-TECHNE CORPTECH | 2.46% | $70.65 | $73.75M | 1.0M |
| EW | EDWARDS LIFESCIENCES CORPEW | 2.46% | $90.46 | $73.61M | 813.7K |
| NOVT | NOVANTA INCNOVT | 2.38% | $162.24 | $71.26M | 439.2K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 28.17% of net assets, top 25 56.56%, across 67 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free